Metraipolis › archive › dc_fb6cfc187d92

Drug development in Alzheimer's disease: the path to 2025 — Europe PMC PMID:27646601

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/27646601
DOI
10.1186/s13195-016-0207-9
License (as archived)
solo-consultazione
Archived
2026-10-08T06:49:03.621Z
SHA-256 of the archived text
57a07f8bad3dc40d6926d72e53b4f3e2620d92b52258174bc7bb064a0e3fa5b9
Stable URL of this page
https://metraipolis.com/documento/dc_fb6cfc187d92

How to cite

Drug development in Alzheimer's disease: the path to 2025 — Europe PMC PMID:27646601 — Europe PMC (en), https://europepmc.org/article/MED/27646601 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fb6cfc187d92 (Metraipolis archive dc_fb6cfc187d92, sha256 57a07f8bad3dc40d6926d72e53b4f3e2620d92b52258174bc7bb064a0e3fa5b9)
BibTeX
@misc{dcfb6cfc187d92,
  title = {Drug development in Alzheimer's disease: the path to 2025 — Europe PMC PMID:27646601},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/27646601},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fb6cfc187d92; sha256 57a07f8bad3dc40d6926d72e53b4f3e2620d92b52258174bc7bb064a0e3fa5b9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/27646601. Agents can read the archived copy with the MCP tool read_document.